{"id":"clm_EA59F20B3B9B","entity":"eli-lilly","predicate":"shares_outstanding","value":"956,580,893 shares","value_json":{"fp":"Q2","fy":2021,"accn":"0000059478-21-000171","form":"10-Q","filed":"2021-08-03","period":"Q2 FY2021","concept":"dei:EntityCommonStockSharesOutstanding"},"valid_from":"2021-07-30","valid_to":"2021-10-22","published":"2021-08-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Eli Lilly and Company shares outstanding: 956,580,893 shares\", as of 2021-07-30 (until 2021-10-22). Claim clm_EA59F20B3B9B, https://asof.is/claim/clm_EA59F20B3B9B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947821000171/0000059478-21-000171-index.htm.","url":"https://asof.is/claim/clm_EA59F20B3B9B","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AD43BA302B07","supersedes":["clm_3086AC877E4A"],"first_seen_at":"2026-11-08T15:32:14.384194+00:00","updated_at":"2026-11-08T15:32:18.231201+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947821000171/0000059478-21-000171-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2021","published_at":"2021-08-03T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2021, filed 2021-08-03"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}